InspireMD (NYSE:NSPR) Stock Price Breaks Below 50-Day Moving Average – Time to Sell?

InspireMD, Inc. (NYSE:NSPR – Get Free Report)’s share price crossed below its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $0.62 and traded as low as $0.5873. InspireMD shares last traded at $0.60, with a volume of 322,378 shares.

InspireMD Price Performance

The firm has a market capitalization of $27.89 million, a P/E ratio of -0.80 and a beta of 0.92. The stock’s fifty day simple moving average is $0.62 and its 200 day simple moving average is $1.02.

Institutional Investors Weigh In On InspireMD

Hedge funds and other institutional investors have recently bought and sold shares of the company. Nantahala Capital Management LLC acquired a new stake in InspireMD in the second quarter valued at approximately $2,363,876. Parkman Healthcare Partners LLC acquired a new position in shares of InspireMD during the second quarter worth $1,692,000. BlackRock Inc. acquired a new position in shares of InspireMD during the second quarter worth $86,000. Finally, Renaissance Technologies LLC acquired a new position in shares of InspireMD during the first quarter worth $29,000. Hedge funds and other institutional investors own 44.78% of the company’s stock.

About InspireMD

(Get Free Report)

InspireMD is a medical technology company focused on developing devices for the treatment of carotid artery disease, a condition that can increase the risk of stroke. The company’s technology is designed to help protect against debris traveling to the brain during procedures to open narrowed arteries. Its lead product is the CGuard carotid stent system, which combines a metal stent with a fine mesh covering called MicroNet. The mesh is designed to help trap plaque and other material while allowing blood to flow through the artery.

Further Reading

Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.